Skip to main content
SpringerPlus
Fig. 3 | SpringerPlus

Fig. 3

From: A comparative study between intravenous and oral alendronate administration for the treatment of osteoporosis

Fig. 3

Comparison of changes in biochemical bone turnover markers between the oral group and the intravenous group (Student’s t test). I suppose bone turnover suppression were relatively low because of effect of other drug combination such as eldecalcitol or past oral alendronate prescription. a Bone alkaline phosphatase (BAP), b collagen type 1 cross-linked N telopeptide (NTX)

Back to article page